Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
critical-care-conditions
Press Release
Nov 30, 2021
Enalare Therapeutics Files New Patent Application for Lead Product ENA-001 - Potentially Extending Global Exclusivity Through 2042
Read More
Press Release
Nov 4, 2021
Enalare Therapeutics Announces First Subject Dosed With Lead Product ENA-001 in a Propofol-Induced Respiratory Depression Study
Read More
Press Release
Nov 2, 2021
Enalare Therapeutics Invited to Present at BARDA Industry Day 2021
Read More
First
Prev
1
Next
Last
